Skip to main content
logo
GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea flag South Korea · Delayed Price · Currency is KRW
814.00
+1.00 (0.12%)
At close: Jul 16, 2026

GL Pharm Tech Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36,86235,26826,04826,03316,72912,426
Revenue Growth
31.41%35.40%0.06%55.62%34.63%3.65%
Gross Profit
14,54414,27910,2768,6834,8483,749
Operating Income
174.8268.48-1,768-3,228-3,255-2,707
Net Income
-131.5812.49-2,337-3,749-790.17-3,727
Earnings Per Share
-1.700.16-31.00-60.23-13.00-73.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,1463,0364,2584,1364,6396,189
Total Debt
20,62418,73314,65017,78513,9107,879
Net Cash (Debt)
-17,478-15,697-10,393-13,650-9,270-1,690
Net Cash Growth
------
Net Cash Per Share
-226.19-203.52-137.83-219.33-149.46-33.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2,735-1,124-4,648-3,760-1,269-2,271
Capital Expenditures
-3,137-3,203-391.81-579.32-6,438-1,328
Free Cash Flow
-5,871-4,327-5,039-4,339-7,707-3,600
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.45%40.49%39.45%33.35%28.98%30.17%
Operating Margin
0.47%0.76%-6.79%-12.40%-19.46%-21.78%
Pretax Margin
-0.18%0.22%-8.95%-15.15%-4.98%-30.92%
Profit Margin
-0.36%0.03%-8.97%-14.40%-4.72%-30.00%
FCF Margin
-15.93%-12.27%-19.35%-16.67%-46.07%-28.97%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-6774.45----
PS Ratio
1.712.402.882.722.786.17